Skip to main content
Clinical Trials/NCT05657730
NCT05657730RecruitingNot Applicable

Analysis of the Intestinal Flora Composition After Consumption of Water Kefir

Lund University2 sites in 1 country63 target enrollmentStarted: November 10, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
63
Locations
2
Primary Endpoint
16S metagenomics based measurement of the bacterial diversity (alpha- and beta diversity indices), and the composition (relative abundance of the bacterial taxa in each sample)

Study Overview

Brief Summary

The goal of this intervention study is to analyse the microbiota composition after the water kefir consumption. The main questions are to evaluate the potential probiotic drink can have beneficial effect on the gut microbiota. Participants will consume the water kefir for two weeks and microbiota will be analysed. Researchers will compare the microbiota composition before and after consumption.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 18-65 years of age.
  • must be able to complete the form digitally.

Exclusion Criteria

  • must not be diagnosed with gastrointestinal diseases, autoimmune diseases or have diseases or medications that cause immune deficiency such as MS, type 1 diabetes, cancer or HIV.
  • must not take antibiotics during the study period.

Outcomes

Primary Outcomes

16S metagenomics based measurement of the bacterial diversity (alpha- and beta diversity indices), and the composition (relative abundance of the bacterial taxa in each sample)

Time Frame: up to 24 weeks

Potential changes of microbiome after consumption of the water kefir will be assessed by analyzing the 16S metagenomics

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Åsa Håkansson

Associate Professor

Lund University

Study Sites (2)

Loading locations...

Similar Trials